Dian Diagnostics GroupLtd (300244) Stock Overview
Provides integrated medical diagnostics solutions with independent diagnostic services in China. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
300244 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Dian Diagnostics Group Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥16.22 |
| 52 Week High | CN¥21.75 |
| 52 Week Low | CN¥10.17 |
| Beta | 0.51 |
| 1 Month Change | 7.35% |
| 3 Month Change | 0.062% |
| 1 Year Change | 20.77% |
| 3 Year Change | -41.91% |
| 5 Year Change | -51.04% |
| Change since IPO | 259.91% |
Recent News & Updates
Recent updates
Is Dian Diagnostics GroupLtd (SZSE:300244) A Risky Investment?
Mar 25
Dian Diagnostics Group Co.,Ltd.'s (SZSE:300244) Price Is Right But Growth Is Lacking After Shares Rocket 43%
Feb 10Dian Diagnostics GroupLtd (SZSE:300244) Will Want To Turn Around Its Return Trends
Jan 02Here's Why Dian Diagnostics GroupLtd (SZSE:300244) Can Manage Its Debt Responsibly
Dec 12Dian Diagnostics Group Co.,Ltd.'s (SZSE:300244) Shares Bounce 37% But Its Business Still Trails The Industry
Oct 04Dian Diagnostics Group Co.,Ltd. (SZSE:300244) Looks Inexpensive But Perhaps Not Attractive Enough
Aug 20Returns On Capital Signal Tricky Times Ahead For Dian Diagnostics GroupLtd (SZSE:300244)
Jul 12Dian Diagnostics GroupLtd (SZSE:300244) Will Pay A Smaller Dividend Than Last Year
Jun 10Dian Diagnostics GroupLtd (SZSE:300244) Seems To Use Debt Quite Sensibly
May 24Dian Diagnostics Group Co.,Ltd. Just Missed Earnings - But Analysts Have Updated Their Models
Apr 30Investors Holding Back On Dian Diagnostics Group Co.,Ltd. (SZSE:300244)
Apr 22Shareholder Returns
| 300244 | CN Healthcare | CN Market | |
|---|---|---|---|
| 7D | -2.3% | -0.07% | -1.6% |
| 1Y | 20.8% | -3.3% | 19.9% |
Return vs Industry: 300244 exceeded the CN Healthcare industry which returned -3.3% over the past year.
Return vs Market: 300244 matched the CN Market which returned 19.9% over the past year.
Price Volatility
| 300244 volatility | |
|---|---|
| 300244 Average Weekly Movement | 4.7% |
| Healthcare Industry Average Movement | 3.6% |
| Market Average Movement | 5.5% |
| 10% most volatile stocks in CN Market | 9.3% |
| 10% least volatile stocks in CN Market | 3.0% |
Stable Share Price: 300244 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 300244's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1996 | 8,773 | Haibin Chen | www.dazd.cn |
Dian Diagnostics Group Co.,Ltd. provides integrated medical diagnostics solutions with independent diagnostic services in China. The company offers laboratory supplies and kits; AI-assisted digital pathology diagnosis solutions, such as nucleic acid extraction and purification system, automatic liquid-based cytology slide preparation and staining system, digital pathology slide scanner, automated pathology slide staining system, genotyping DNA test kit, human papillomavirus nucleic acid detection kit, PCR system and detection system, and virus collection and preservation system; and multi-omics platform services.
Dian Diagnostics Group Co.,Ltd. Fundamentals Summary
| 300244 fundamental statistics | |
|---|---|
| Market cap | CN¥10.25b |
| Earnings (TTM) | -CN¥431.43m |
| Revenue (TTM) | CN¥10.50b |
Is 300244 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 300244 income statement (TTM) | |
|---|---|
| Revenue | CN¥10.50b |
| Cost of Revenue | CN¥7.52b |
| Gross Profit | CN¥2.99b |
| Other Expenses | CN¥3.42b |
| Earnings | -CN¥431.43m |
Last Reported Earnings
Sep 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.71 |
| Gross Margin | 28.44% |
| Net Profit Margin | -4.11% |
| Debt/Equity Ratio | 32.2% |
How did 300244 perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/11/19 16:00 |
| End of Day Share Price | 2025/11/19 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Dian Diagnostics Group Co.,Ltd. is covered by 17 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Pei Cheng | China Galaxy Securities Co., Ltd. |
| Jin Zhang | China International Capital Corporation Limited |
| Sophia Zhang | China Stock Investment Research Co. Ltd. (GZ500..com) |